Cargando…
Systems Immunology Characterization of Novel Vaccine Formulations for Mycoplasma hyopneumoniae Bacterins
We characterized five different vaccine candidates and a commercial vaccine in terms of safety, immunogenicity and using a systems vaccinology approach, with the aim to select novel vaccine candidates against Mycoplasma hyopneumoniae. Seven groups of six M. hyopneumoniae-free piglets were primo- and...
Autores principales: | Matthijs, Anneleen M. F., Auray, Gaël, Jakob, Virginie, García-Nicolás, Obdulio, Braun, Roman O., Keller, Irene, Bruggman, Rémy, Devriendt, Bert, Boyen, Filip, Guzman, Carlos A., Michiels, Annelies, Haesebrouck, Freddy, Collin, Nicolas, Barnier-Quer, Christophe, Maes, Dominiek, Summerfield, Artur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543460/ https://www.ncbi.nlm.nih.gov/pubmed/31178860 http://dx.doi.org/10.3389/fimmu.2019.01087 |
Ejemplares similares
-
Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae
por: Matthijs, Anneleen Marguerite Filip, et al.
Publicado: (2019) -
Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs
por: Maes, Dominiek, et al.
Publicado: (2021) -
Different local, innate and adaptive immune responses are induced by two commercial Mycoplasma hyopneumoniae bacterins and an adjuvant alone
por: Beuckelaere, Lisa, et al.
Publicado: (2022) -
Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains
por: Michiels, Annelies, et al.
Publicado: (2017) -
Clinical impact of deoxynivalenol, 3-acetyl-deoxynivalenol and 15-acetyl-deoxynivalenol on the severity of an experimental Mycoplasma hyopneumoniae infection in pigs
por: Michiels, Annelies, et al.
Publicado: (2018)